Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

In Teva Branded Pharm. Prods. R&D v. Amneal Pharms. of N.Y., LLC, the US District Court for the District of New Jersey ordered Teva to delist ...

NHS Grampian has introduced a traffic light system for GPs and other health care professionals highlighting the carbon ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

Topline results were announced from a trial evaluating albuterol/budesonide inhaler in patients with intermittent or mild persistent asthma.

The global metered dose inhalers (MDI) market is poised for significant growth, with an estimated market size of USD 26,322.9 million in 2023, up from USD 25,208.9 million in 2022. According to a ...

Early fall is when asthma flare-ups peak in the U.S., and a warming climate is bad news for sufferers: It means more ...

Our Nursing in Practice quick quizzes aim to test your knowledge through a series of illustrative cases and scenarios. Work ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Pharmaceutical companies are looking to change that with lower-emitting inhalers that they plan to roll out by the end of the decade. Metered-dose inhalers — pressurized devices that release a ...